Cargando…
Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome
OBJECTIVE: To determine serum concentrations of the soluble forms of vascular cell adhesion molecule 1 (VCAM-1), intracellular adhesion molecule 1 (ICAM-1), and E-selectin in ventilated neonatal and pediatric intensive care patients with varying severity of multiorgan dysfunction syndrome (MODS) wit...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095409/ https://www.ncbi.nlm.nih.gov/pubmed/17124613 http://dx.doi.org/10.1007/s00134-006-0453-6 |
_version_ | 1783510664305704960 |
---|---|
author | Krueger, Marcus Heinzmann, Andrea Nauck, Markus |
author_facet | Krueger, Marcus Heinzmann, Andrea Nauck, Markus |
author_sort | Krueger, Marcus |
collection | PubMed |
description | OBJECTIVE: To determine serum concentrations of the soluble forms of vascular cell adhesion molecule 1 (VCAM-1), intracellular adhesion molecule 1 (ICAM-1), and E-selectin in ventilated neonatal and pediatric intensive care patients with varying severity of multiorgan dysfunction syndrome (MODS) with or without infection-triggered organ failure. DESIGN AND SETTING: Prospective pilot study, a level III neonatal and pediatric intensive care unit at a University children's Hospital. PATIENTS: We studied 22 ventilated pediatric (n = 15) and neonatal (n = 7) intensive care patients (aged 3 days–16 years). Inclusion criteria were mechanical ventilation and signs of at least one additional organ dysfunction (cardiovascular, respiratory, neurological, hematological, or renal). MEASUREMENTS AND RESULTS: Serum concentrations of the adhesion molecules were analyzed on the day of maximum organ dysfunction score and were quantitated by a sandwich ELISA technique. The overall mortality rate was 36% (8/22). Dysfunction of three or more organ systems was defined as MODS and was associated with a significant increase in VCAM-1 serum levels relative to dysfunction of three or fewer organ systems [median 1239 ng/ml (IQR 928–1615) vs. 766 ng/ml (644–915)]. A significant difference in E-selectin serum levels was found between organ failure of infectious (median 131 ng/ml, IQR 112–146) and noninfectious origin (68 ng/ml 49–105). CONCLUSIONS: Determination of adhesion molecules in pediatric intensive care patients raises the possibility of more specific pathophysiological understanding. E-selectin showed significantly different serum levels between infectious and noninfectious causes of organ failure. |
format | Online Article Text |
id | pubmed-7095409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-70954092020-03-26 Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome Krueger, Marcus Heinzmann, Andrea Nauck, Markus Intensive Care Med Pediatric Brief Report OBJECTIVE: To determine serum concentrations of the soluble forms of vascular cell adhesion molecule 1 (VCAM-1), intracellular adhesion molecule 1 (ICAM-1), and E-selectin in ventilated neonatal and pediatric intensive care patients with varying severity of multiorgan dysfunction syndrome (MODS) with or without infection-triggered organ failure. DESIGN AND SETTING: Prospective pilot study, a level III neonatal and pediatric intensive care unit at a University children's Hospital. PATIENTS: We studied 22 ventilated pediatric (n = 15) and neonatal (n = 7) intensive care patients (aged 3 days–16 years). Inclusion criteria were mechanical ventilation and signs of at least one additional organ dysfunction (cardiovascular, respiratory, neurological, hematological, or renal). MEASUREMENTS AND RESULTS: Serum concentrations of the adhesion molecules were analyzed on the day of maximum organ dysfunction score and were quantitated by a sandwich ELISA technique. The overall mortality rate was 36% (8/22). Dysfunction of three or more organ systems was defined as MODS and was associated with a significant increase in VCAM-1 serum levels relative to dysfunction of three or fewer organ systems [median 1239 ng/ml (IQR 928–1615) vs. 766 ng/ml (644–915)]. A significant difference in E-selectin serum levels was found between organ failure of infectious (median 131 ng/ml, IQR 112–146) and noninfectious origin (68 ng/ml 49–105). CONCLUSIONS: Determination of adhesion molecules in pediatric intensive care patients raises the possibility of more specific pathophysiological understanding. E-selectin showed significantly different serum levels between infectious and noninfectious causes of organ failure. Springer-Verlag 2006-11-24 2007 /pmc/articles/PMC7095409/ /pubmed/17124613 http://dx.doi.org/10.1007/s00134-006-0453-6 Text en © Springer-Verlag 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Pediatric Brief Report Krueger, Marcus Heinzmann, Andrea Nauck, Markus Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome |
title | Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome |
title_full | Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome |
title_fullStr | Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome |
title_full_unstemmed | Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome |
title_short | Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome |
title_sort | adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome |
topic | Pediatric Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095409/ https://www.ncbi.nlm.nih.gov/pubmed/17124613 http://dx.doi.org/10.1007/s00134-006-0453-6 |
work_keys_str_mv | AT kruegermarcus adhesionmoleculesinpediatricintensivecarepatientswithorgandysfunctionsyndrome AT heinzmannandrea adhesionmoleculesinpediatricintensivecarepatientswithorgandysfunctionsyndrome AT nauckmarkus adhesionmoleculesinpediatricintensivecarepatientswithorgandysfunctionsyndrome |